Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Shrividya Iyer

Department of Global Health Economics and Outcomes Research, Pfizer, Inc., New York, NY, USA

Biography

Dr. Shrividya Iyer is an associate professor in the department of Global Health Economics and Outcomes Research, Pfizer, New York, NY, USA. He published 20 articles in many journals and the articles are informative and got good citations.
Publications

Predictive and Prognostic Value of ALK Gene Rearrangement in Non- Small Cell Lung Cancer

Anaplastic Lymphoma Kinase (ALK) is a relatively new as an oncogenic driver and a therapeutic target in Non-Small Cell Lung Cancer (NSCLC); the prognostic and predictive implications of ALK-positivity in NSCLC is far from clear and no large-scale studies have been reported to date. In the current review, we summarize published data examining the va... Read More»

Kimary Kulig, Shrividya Iyer, Yi Wang and Ping Yang

Research Article: Epidemiol 2014, 4: 146

DOI: 10.4172/2161-1165.1000146

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top